ECSP10010048A - ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MENSTRAL CELLS, AMNITIC FLUID, UMBILICAL CORD BLOOD OR OTHER SAMPLES - Google Patents

ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MENSTRAL CELLS, AMNITIC FLUID, UMBILICAL CORD BLOOD OR OTHER SAMPLES

Info

Publication number
ECSP10010048A
ECSP10010048A EC2010010048A ECSP10010048A ECSP10010048A EC SP10010048 A ECSP10010048 A EC SP10010048A EC 2010010048 A EC2010010048 A EC 2010010048A EC SP10010048 A ECSP10010048 A EC SP10010048A EC SP10010048 A ECSP10010048 A EC SP10010048A
Authority
EC
Ecuador
Prior art keywords
fluid
test
sample
umbilical cord
cord blood
Prior art date
Application number
EC2010010048A
Other languages
Spanish (es)
Inventor
Mercedes A Walton
Julie G Allickson
Original Assignee
Cryo Cell Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryo Cell Internat Inc filed Critical Cryo Cell Internat Inc
Publication of ECSP10010048A publication Critical patent/ECSP10010048A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proveen métodos para obtener y probar o analizar una muestra de fluido humano o celular obtenida por punción no venosa y no arterial, o fluido corporal o muestra celular humana para detectar la presencia de, al menos, una enfermedad infecciosa. La muestra puede ser fluido menstrual, células endometriales menstruales, sangre de cordón umbilical o fluido amniótico. Se puede realizar una prueba confirmatoria de una muestra de sangre arterial o venosa correspondiente para comparar con los resultados de la prueba para la muestra de fluido humano o muestra celular no venosa y no arterial. La prueba puede comprender una prueba de detección o prueba confirmatoria.Methods are provided to obtain and test or analyze a sample of human or cellular fluid obtained by non-venous and non-arterial puncture, or body fluid or human cell sample to detect the presence of at least one infectious disease. The sample can be menstrual fluid, menstrual endometrial cells, umbilical cord blood or amniotic fluid. A confirmatory test of a corresponding arterial or venous blood sample may be performed to compare with the test results for the human fluid sample or non-venous and non-arterial cell sample. The test may comprise a screening test or confirmatory test.

EC2010010048A 2007-09-14 2010-03-23 ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MENSTRAL CELLS, AMNITIC FLUID, UMBILICAL CORD BLOOD OR OTHER SAMPLES ECSP10010048A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99374807P 2007-09-14 2007-09-14
US19160108P 2008-09-09 2008-09-09

Publications (1)

Publication Number Publication Date
ECSP10010048A true ECSP10010048A (en) 2010-06-29

Family

ID=40452371

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010048A ECSP10010048A (en) 2007-09-14 2010-03-23 ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MENSTRAL CELLS, AMNITIC FLUID, UMBILICAL CORD BLOOD OR OTHER SAMPLES

Country Status (15)

Country Link
EP (1) EP2200620A4 (en)
JP (1) JP2010539479A (en)
KR (1) KR20100063089A (en)
CN (1) CN101854942A (en)
AR (1) AR068449A1 (en)
AU (1) AU2008299884A1 (en)
BR (1) BRPI0817333A2 (en)
CA (1) CA2699491A1 (en)
CL (1) CL2008002749A1 (en)
CR (1) CR11315A (en)
EC (1) ECSP10010048A (en)
MX (1) MX2010002910A (en)
NI (1) NI201000037A (en)
TW (1) TW200918020A (en)
WO (1) WO2009035706A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015018035A (en) * 2013-07-03 2016-07-06 Coyne Ip Holdings Llc Methods for predicting responses to chemical or biologic substances.
AU2015302059B2 (en) 2014-08-12 2020-02-06 Nextgen Jane, Inc. System and method for monitoring health based on collected bodily fluid
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725481A (en) * 1996-05-17 1998-03-10 A. Fem Medical Corporation Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
MX2009009414A (en) * 2007-03-01 2009-11-02 Cryo Cell Int Procurement, isolation and cryopreservation of endometrial/menstrual cells.

Also Published As

Publication number Publication date
CN101854942A (en) 2010-10-06
NI201000037A (en) 2011-06-21
AR068449A1 (en) 2009-11-18
EP2200620A4 (en) 2010-10-27
CL2008002749A1 (en) 2010-05-07
AU2008299884A1 (en) 2009-03-19
EP2200620A1 (en) 2010-06-30
TW200918020A (en) 2009-05-01
KR20100063089A (en) 2010-06-10
BRPI0817333A2 (en) 2017-06-13
JP2010539479A (en) 2010-12-16
CA2699491A1 (en) 2009-03-19
WO2009035706A1 (en) 2009-03-19
MX2010002910A (en) 2010-05-24
CR11315A (en) 2010-08-13

Similar Documents

Publication Publication Date Title
PA8796101A1 (en) ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MONTHLY CELLS, AMNIOTIC FLUID, BLOOD OF UMBILICAL CORDON OR OTHER SAMPLES
WO2006091412A3 (en) Adamts-7 as a biomarker for cancers of epithelial origin
ES2656962T3 (en) Methods to assess the receptivity of a patient's endometrium
BR112015026248A2 (en) biological fluid collection device and biological fluid separation and testing system
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
WO2014170497A3 (en) Method for identifying the quantitative cellular composition in a biological sample
DE602005017519D1 (en) AUTOMATIC GLYCOFINGERPRINT STRATEGY
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
BRPI0311233B8 (en) in vitro methods for screening a patient for hepatocellular carcinoma (hcc), and for diagnosing hcc in a patient, as well as a method and kit for detecting or determining the level of gpc3 in a specimen
WO2006024466A3 (en) Test device for the in vitro diagnosis of multi-analyte tests and the use thereof
EP4306955A3 (en) Integrated functional and molecular profiling of cells
PE20141565A1 (en) METHODS TO DETECT HUMAN PAPILLOMAVIRUS AND PROVIDE PROGNOSIS FOR SCAMOUS CELL CARCINOMA OF THE HEAD AND NECK
ECSP10010048A (en) ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MENSTRAL CELLS, AMNITIC FLUID, UMBILICAL CORD BLOOD OR OTHER SAMPLES
BR112015014232A2 (en) acute kidney injury
ATE550660T1 (en) DIAGNOSIS OF A DISEASE AND CLASSIFICATION OF CANCER USING MEMBRANE ELECTROPHORESIS
MX2009009114A (en) Test strip with integrated lancet.
WO2009059244A3 (en) Cell-based antioxidant protection assay
ES2530357T3 (en) Method to detect a plasmodium infection
WO2010133881A3 (en) Tissue analysis
WO2014126487A3 (en) Diagnosis and detection of dengue virus infection using chicken egg antibodies
ATE545027T1 (en) SAMPLE COLLECTION PROCEDURES
CN203417215U (en) Novel breast tissue biopsy device
CN210232758U (en) Urine sample taking and placing clamp
Razmjou for diagnosis of strongyloidiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 113 (6); 326–331, 2019.
Badyal et al. Reference range of glycated hemoglobin in the diagnosis of diabetes mellitus.